Gregory Drohan

TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB­2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada.

Alkaline Spring, Inc. supplies bottled water products. It offers nano h2.0 and revelstoke water 8.0 ph water products. The company is headquartered in Edmonton, Canada.

World Class Extractions (Ontario), Inc. engages in the development and extraction of hemp and cannabis industries. The company is headquartered in Toronto, Canada.

Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada.

PhytoPain Pharma, Inc. engages in the development and commercialization of botanical medicines. The company is headquartered in Canada, Canada.

Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada.

BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun.

Climb Credit, Inc. engages in the provision of educational loans to school students. The company was founded by Vishal Garg, Zander Rafael, Amit Sinha and Raza Munir in 2014 and is headquartered in New York, NY.

Videojet Technologies, Inc. manufactures industrial printers, marking, coding systems, and accessories for the product identification industry. The firm offers ink jets, laser marking products, thermal transfer over printers, case coding and labeling, thermal ink jets, and commercial graphics and addressing products. The company was founded by Albert Blake Dick III in 1969 and is headquartered in Wood Dale, IL.

Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada.

Cardinal Meat Specialists Ltd. produces and markets meat products. It offers beef, rib beef, sirloin beef, chicken, and veggie burgers; beef ribs; and pulled beef au jus and meat loaf. The company was founded by Ralph Cator in 1966 and is headquartered in Brampton, Canada.

Prime Blockchain, Inc. engages in the provision of engineering services. The company was founded on February 24, 2004 and is headquartered Verdun, Canada.

Prismic Pharmaceuticals, Inc. engages in the research and development of prescription drugs for kidney disease, mental health, and chronic pain. It also offers medical foods for patients with chronic kidney disease, and depression and bipolar disorder. The company was founded by Zachary Dutton, Danilo Casadei Massari, and Peter J. Moriarty in 2011 and is headquartered in Worcester, MA.

Pharmaceutical Marketing Club of Québec operates as a pharmaceutical marketing club. The company is headquartered in Pointe-Claire. Canada.

Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada.

Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA.

Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada.